Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients

NO_LONGER_AVAILABLEEXPANDED_ACCESS
Timeline

Start Date

Not specified

Conditions
Lung Transplant
Interventions
DRUG

Cyclosporine Inhalation Solution

Cyclosporine USP Inhalation Solution (CIS) 300mg/4.8 mL delivered via a disposable nebulizer. A titration phase of 10 days is recommended starting with 100 mg and then increasing over the 10 days to a maximum of 300 mg or the highest tolerated dose.

Trial Locations (8)

15213

University of Pittsburgh Medical Center, Pittsburgh

21201

University of Maryland Medical Center, Baltimore

32610

University of Florida Health Sciences Center, Gainesville

33606

Tampa General Hospital, Tampa

44195

Cleveland Clinic, Cleveland

77030

Baylor Clinic, Baylor College of Medicine, Houston

94143

University of California at San Francisco, San Francisco

02115

Children's Hospital Boston, Boston

Sponsors
All Listed Sponsors
lead

APT Pharmaceuticals, Inc.

INDUSTRY